Answers are grounded in this paper and cite their sources.
Randomized trial evaluates Aptamin C's impact on NK cell activity, suggesting it enhances immune response beyond vitamin C.
Introduction NK cells are crucial for innate immunity and rapidly target abnormal cells through ligand-receptor signaling, without prior sensitization. Vitamin C is a bioenhancer of NK cells; however, its susceptibility to oxidation limits its efficacy in NK cell activation. This study evaluated the efficacy of Aptamin C, a stable conjugate of vitamin C and an aptamer, in enhancing NK cell activation. Methods For the in vivo study, 109 participants were administered Aptamin C (36.057 mg/day) or a placebo for 4 weeks. NK cell cytotoxicity and serum levels of NK cell related cytokines and cytotoxic granules were assessed. In parallel, in vitro experiments were conducted using NK-92 cells to compare the effects of Aptamin C with those of conventional vitamin C on NK cell proliferation, survival, and cytotoxic activity. Results In vivo, Aptamin C administration resulted in significant increases in NK cell cytotoxicity at weeks 2 and 4. Additionally, cytokine and granule levels associated with NK cell activity peaked in the serum 4 weeks after Aptamin C intake. Consistently, in vitro experiments revealed that Aptamin C treatment led to superior proliferation, survival, and cytotoxic granule production in NK-92 cells relative to vitamin C-treated controls. Conclusion These results demonstrate that Aptamin C more effectively enhances NK cell activity than vitamin C, highlighting its potential as a novel immunomodulatory supplement for NK cell based immune enhancement strategies. Funding Source This work was supported by N Therapeutics Co., Ltd. and Nexmos.
No takes yet. Share an insight, caveat, or question.
Ahn et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: